Page last updated: 2024-08-17

triamcinolone acetonide and Macular Degeneration

triamcinolone acetonide has been researched along with Macular Degeneration in 144 studies

Research

Studies (144)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (2.08)	18.2507
2000's	109 (75.69)	29.6817
2010's	31 (21.53)	24.3611
2020's	1 (0.69)	2.80

Authors

Authors	Studies
Ando, R; Hirooka, K; Ishida, S; Kase, S; Noda, K; Saito, M	1
Balakrishnan, D; Oli, A	1
Jones, D; McAvoy, K; Thakur, RRS	1
Kawano, H; Nakamura, M; Otsuka, H; Sakamoto, T; Sonoda, S	1
Geltzer, A; Turalba, A; Vedula, SS	2
Gad, MA; Hamza, W; Shahin, M	1
Guthrie, MJ; Kang-Mieler, JJ; Mieler, WF; Osswald, CR; Valio, NL	1
Grover, A; Hirani, A; Lee, YW; Pathak, Y; Sutariya, V	1
Benz, MS; Brown, DM; Chen, E; Fish, RH; Kim, RY; Li, AL; Major, JC; OʼMalley, RE; Schefler, AC; Wang, R; Wong, TP; Wykoff, CC	1
Saperstein, DA; Singh, CN	1
Bunse, A; Frimpong-Boateng, A; Roider, J; Rüfer, F	1
Michels, S; Polak, K; Sacu, S; Schmidt-Erfurth, U; Varga, A; Vécsei-Marlovits, PV; Weigert, G	1
Brue, C; Chang, LK; Freund, KB; Klancnik, JM; Slakter, JS; Spaide, RF	1
Gotoh, N; Iwama, D; Otani, A; Sasahara, M; Tamura, H; Tsujikawa, A; Yodoi, Y; Yoshimura, N	1
Harder, B; Ihloff, AK; Jonas, JB; Kreissig, I; Libondi, T; Schlichtenbrede, F; Spandau, UH; Vossmerbaeumer, U	1
Lo Giudice, G; Maritan, V; Midena, E; Piermarocchi, S; Sartore, M; Segato, T	1
Kaplan, HJ; Schaal, S; Tezel, TH	1
Fernandez-Munoz, M; Montero, JA; Ruiz-Moreno, JM; Sanabria, MR	1
Angulo Bocco, MC; Coscas, G; Glacet-Bernard, A; Soubrane, G; Zourdani, A	1
Aue, A; Lie, S; Polak, K; Sacu, S; Schmidt-Erfurth, U; Simader, C	1
Gosławski, W; Karczewicz, D; Lubiński, W; Mozolewska-Piotrowska, K; Szych, Z	1
Amat, P; Lugo, FL; Montero, JA; Ruiz-Moreno, JM	1
Smiddy, WE	1
Gutfleisch, M; Heimes, B; Lommatzsch, A; Pauleikhoff, D; Spital, G; Zeimer, M	1
Ishikawa, K; Ito, Y; Kondo, M; Nishihara, H; Ozawa, S; Piao, CH; Terasaki, H	1
Adam, A; Bartz-Schmidt, KU; Boeyden, V; Claes, C; Eckardt, C; Eckert, T; Grisanti, S; Kaiserling, E; Pertile, G; Scharioth, GB; Shinoda, K; Szurman, P; Tatar, O; Yoeruek, E	1
Bakri, SJ; Edwards, AO; Pulido, JS; Risco, M	1
Falavarjani, KG; Modarres, M	1
Golubkina, L; Jonas, JB; Libondi, T; Rensch, F; Schlichtenbrede, F; Spandau, UH	1
Neuhann, IM; Voelker, M; Ziemssen, F	1
Avgikos, KN; Horgan, SE; Hu, K; Sivaraj, RR	1
Maberley, D	1
Kiernan, DF; Mieler, WF	1
Katome, T; Nagasawa, T; Naito, T; Shiota, H	1
Haneda, S; Kawasaki, R; Saito, K; Tsuchiya, D; Yamamoto, T; Yamashita, H	1
Dunavoelgyi, R; Pruente, C; Sacu, S; Schmidt-Erfurth, U; Simader, C	1
Hatta, Y; Ishikawa, K; Ito, Y; Nishihara, H; Ozawa, S; Terasaki, H	1
Bhavsar, AR; Bressler, NM; Brucker, AJ; Elman, MJ; Glassman, AR; Googe, JM; Stockdale, CR	1
Baklouti, K; Bouraoui, R; Chebil, A; el Matri, L; Kort, F; Mghaieth, F	1
Agostini, H; Böhringer, D; Feltgen, N; Lubrich, B; Ness, T	1
Kimura, H; Kuroda, S; Toyokawa, N	1
Jonas, JB; Tao, Y	1
Hajouli, N; Hiesch, A; Quintyn, JC	1
Kim, SJ; Toma, HS	1
Arcidiacono, B; Becerra, EM; Danzi, P; Gandolfo, F; Morescalchi, F; Nascimbeni, G; Semeraro, F	1
Cennamo, G; Cesarano, I; D'Amico, G; De Crecchio, G; Finelli, M; Forte, R	1
Bardak, Y; Cekiç, O; Yeşildağ, A	1
Arroyo, JG; Ceron, OM; Gautam, S; Kinoshita, T; Kovacs, KD; Murtha, TJ; Quirk, MT	1
Agnieszka, KT	1
Kubicka-Trzaska, A; Wilańska, J	1
Grabska-Liberek, I; Jamrozy-Witkowska, A; Jankowska-Lech, I; Kowalska, K; Nowosielska, A; Terelak-Borys, B	1
Bonini-Filho, MA; Crispim, PT; Cunha, AS; Damico, FM; Haddad, A; Jorge, R; Maia-Filho, A; Messias, A; Oliveira, RC; Ribeiro, JA; Saliba, JB; Scott, IU; Siqueira, RC	1
Bandello, F; Giatsidis, S; Introini, U; Scotti, F; Setaccioli, M; Torres Gimeno, A	1
Cheung, CS; Devenyi, RG; Kertes, PJ; Lam, WC; Lui, A; Wong, AW	1
Hirose, S; Ishida, S; Kitamei, H; Noda, K; Saito, W; Yoshizawa, C	1
Nentwich, MM; Ulbig, MW	1
Lanzetta, P; Sarao, V; Veritti, D	1
Degenring, R; Jonas, JB; Kreissig, I	2
Holz, FG; Miller, DW	1
Degenring, R; Hugger, P; Jonas, JB; Kreissig, I; Panda-Jonas, S; Sauder, G	1
Billson, F; Chua, W; Gillies, MC; Hunyor, AB; Luo, W; Mitchell, P; Penfold, P; Simpson, JM	1
Degenring, RF; Jonas, JB; Kreissig, I	3
Maranan, L; Sorenson, J; Spaide, RF	2
Akkoyun, I; Budde, WM; Degenring, RF; Jonas, JB; Kreissig, I	1
Danis, RP; Harris, A; Pratt, LM; Rechtman, E	1
Degenring, RF; Jonas, JB; Kamppeter, B; Kreissig, I	1
Billson, FA; Chua, W; Gillies, MC; Hunyor, AB; Luo, W; Mitchell, P; Penfold, P; Simpson, JM; Zhu, M	1
Jonas, JB	2
Campbell, I; Groenwald, C; Lancaster, E; Wong, D	1
Bleyl, U; Jonas, JB	1
Degenring, RF; Jonas, JB	2
Akkoyun, I; Degenring, RF; Friedemann, T; Jonas, JB; Kreissig, I	1
Dunbar, MT; Hunter, MA; Rosenfeld, PJ	1
Ball, M; Craig, J; Gillies, MC; Kuzniarz, M; Luo, W; Simpson, JM	1
Akkoyun, I; Degenring, RF; Jonas, JB; Kreissig, I	1
Haamann, PH; Klitgaard, TL; Larsen, M; Villumsen, JE	1
Arevalo, JF; Garcia, RA; Mendoza, AJ	1
Eandi, CM; Freund, KB; Klais, CM; Yannuzzi, LA	1
Harder, B; Jonas, JB; Kamppeter, BA; Spandau, UH; Vossmerbaeumer, U	2
Arevalo, JF; Fernández, CF; Mendoza, AJ	1
Gillies, MC; Larsson, J	2
Kak, R; Mitchell, KW; Sandhu, SS; Talks, SJ; Van de Moere, A	1
Bardak, Y; Cekiç, O; Tiğ, SU	1
Agurto-Rivera, R; Colina-Luquez, J; Diaz-Rubio, J; Fromow-Guerra, J; Jager, RD; Macky, TA; Martinez-Jardon, S; Papa-Oliva, G; Quiroz-Mercado, H; Torres-Bernal, L	1
Binder, S; Krebs, I; Stolba, U	1
Augustin, AJ; Schmidt-Erfurth, U	2
Gillies, MC; Simpson, JM; Zhu, M	1
Coupland, SG; Kertes, PJ	1
Calabria, G; Cicinelli, S; Ghiglione, D; Lai, S; Nasciuti, F; Nicolò, M	1
Harder, B; Jonas, JB; Kamppeter, BA; Spandau, UH	1
Aue, A; Geitzenauer, W; Michels, S; Sacu, S; Schmidt-Erfurth, U; Simader, C	1
Harder, B; Jonas, JB; Kreissig, I; Spandau, UH	1
Ito, M; Okubo, A; Sakamoto, T; Sonoda, Y; Yamakiri, K	1
Morescalchi, F; Ratiglia, R; Staurenghi, G; Viola, F	1
Augustin, A; Michels, S; Schmidt-Erfurth, U	1
Zarbin, M	1
Bergamini, F; Bottoni, F; Massacesi, A; Romano, M	1
Barthelmes, D; Bösch, MM; Fleischhauer, J; Helbig, H; Kurz-Levin, MM; Sutter, FK	1
Akkoyun, I; Degenring, RF; Jonas, JB; Kamppeter, BA; Kreissig, I; Spandau, UH; Vossmerbaeumer, U	1
Ansari-Shahrezaei, S; Ergun, E; Krepler, K; Maár, N; Stur, M; Wedrich, A; Wimpissinger, B	1
Bencić, G; Konjević Pernar, S; Mandić, Z; Pentz, A; Vatavuk, Z	1
Menéndez de Lucas, JA; Morcillo Laiz, R	1
Bandello, F; Chakravarthy, U; Chong, V; Creuzot-Garcher, C; Dimitrakos, SA; Korobelnik, JF; Larsen, M; Monés, J; Pauleikhoff, D; Pournaras, CJ; Soubrane, G; Staurenghi, G; Virgili, G; Wolf, S	1
González Barcia, M; Lorenzo Carrero, J; Pérez Flores, I	1
Chaudhry, NL; Gandhi, JS; Jalil, A; Odat, TM; Yodaiken, M	1
Arias, L; Badia, M; Garcia-Arumi, J; Pujol, O; Ramon, JM; Rubio, M	2
Harder, B; Jonas, JB; Kamppeter, BA; Schlichtenbrede, F; Spandau, UH; Strueven, V	1
Arnaud, C; Audrey, L; Fournie, P; Leparmentier, A; Mathis, A; Quintyn, JC	1
Cheng, L; Falkenstein, I; Freeman, WR; Kozak, I; Tammewar, AM	1
Bienias, W; Nowak, JZ	1
Kak, R; Sandhu, SS; Talks, SJ; van de Moere, A	1
Barthelmes, D; Fleischhauer, JC; Helbig, H; Kurz-Levin, MM; Scherrer, M; Sutter, FK	1
Gómez-Ulla, F; López Gálvez, MI	1
Apte, RS; Kymes, SM; Schadlu, R	1
Binder, S; Goll, A; Krebs, I; Krepler, K; Stolba, U	1
Kolluru, C; Krishnadas, R; Mahalakshmi, R; Prasad, NM; Shukla, D; Vidhya, N	1
Inoue, Y; Iriyama, A; Obata, R; Takahashi, H; Tamaki, Y; Yanagi, Y	1
Bressler, NM; Gilson, MM; Jabs, DA; Solomon, SD; Thorne, JE; Wilson, DJ	1
Krishnan, R; Kumar, N; Wishart, PK	1
Brajac, I; Loncarek, K; Stalekar, H	1
Chaudhary, V; Hooper, PL; Mao, A; Sheidow, TG	1
Colucciello, M	1
Bartz-Schmidt, KU; Eckardt, C; Grisanti, S; Kaiserling, E; Mohr, A; Pertile, G; Shinoda, K; Szurman, P; Tatar, O; Yoeruek, E	1
Allingham, RR; Fekrat, S; Im, L; Singh, I; Stinnett, S	1
Nehemy, MB; Nehemy, PG; Schachat, AP; Vasconcelos-Santos, DV	1
Billson, FA; Challa, JK; Gillies, MC; Gyory, JF; Hunyor, AB; Penfold, PL	1
Beaumont, PE; Wingate, RJ	1
Anliker, W; Ciulla, TA; Danis, RP; Pratt, LM	1
Gillies, MC; King, NJ; Madigan, MC; Penfold, PL; Provis, JM; Wen, L	1
Billson, FA; Gyory, J; Penfold, PL; Wong, JG	1
Billson, FA; Gyory, JF; Hunyor, AB; Penfold, PL	1

Reviews

13 review(s) available for triamcinolone acetonide and Macular Degeneration

Article	Year
Surgical implantation of steroids with antiangiogenic characteristics for treating neovascular age-related macular degeneration. The Cochrane database of systematic reviews, 2013, Jan-31, Issue:1 Topics: Angiogenesis Inhibitors; Choroidal Neovascularization; Drug Implants; Humans; Macular Degeneration; Photochemotherapy; Pregnadienediols; Randomized Controlled Trials as Topic; Triamcinolone Acetonide	2013
The use of intraocular corticosteroids. Expert opinion on pharmacotherapy, 2009, Volume: 10, Issue:15 Topics: Animals; Anti-Inflammatory Agents; Clinical Trials as Topic; Drug Implants; Glucocorticoids; Humans; Injections; Macular Degeneration; Retinal Vein Occlusion; Triamcinolone Acetonide; Uveitis; Vitreous Body	2009
Clinical evidence of intravitreal triamcinolone acetonide in the management of age-related macular degeneration. Current drug targets, 2011, Volume: 12, Issue:2 Topics: Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents; Blindness; Choroidal Neovascularization; Combined Modality Therapy; Delayed-Action Preparations; Humans; Hyperthermia, Induced; Intravitreal Injections; Macular Degeneration; Photochemotherapy; Photosensitizing Agents; Porphyrins; Triamcinolone Acetonide; Vascular Endothelial Growth Factors; Verteporfin; Wet Macular Degeneration	2011
The therapeutic potential of intraocular depot steroid systems: developments aimed at prolonging duration of efficacy. Deutsches Arzteblatt international, 2012, Volume: 109, Issue:37 Topics: Adrenal Cortex Hormones; Biological Availability; Delayed-Action Preparations; Dexamethasone; Diabetic Retinopathy; Drug Implants; Fluocinolone Acetonide; Humans; Intravitreal Injections; Macular Degeneration; Macular Edema; Posterior Eye Segment; Retinal Vein Occlusion; Triamcinolone Acetonide; Uveitis, Posterior	2012
[Pharmacological therapy for age-related macular degeneration. Current developments and perspectives]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2003, Volume: 100, Issue:2 Topics: Adrenal Cortex Hormones; Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents; Choroidal Neovascularization; Clinical Trials as Topic; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Disease Models, Animal; Endothelial Growth Factors; Eye Proteins; Fluorescein Angiography; Fundus Oculi; Haplorhini; Humans; Intercellular Signaling Peptides and Proteins; Lymphokines; Macular Degeneration; Matrix Metalloproteinase Inhibitors; Nerve Growth Factors; Neuroprotective Agents; Photochemotherapy; Placebos; Proteins; Rats; Serpins; Time Factors; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Visual Acuity	2003
[Treatment of oedematous, proliferative and neovascular diseases by intravitreal triamcinolone acetonide]. Klinische Monatsblatter fur Augenheilkunde, 2003, Volume: 220, Issue:6 Topics: Angiogenesis Inhibitors; Anti-Inflammatory Agents; Clinical Trials as Topic; Glucocorticoids; Humans; Injections; Macular Degeneration; Macular Edema; Retinal Neovascularization; Triamcinolone Acetonide; Vitreoretinopathy, Proliferative; Vitreous Body	2003
[Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases]. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2004, Volume: 101, Issue:2 Topics: Aged; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Combined Modality Therapy; Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Intraocular Pressure; Iris Diseases; Macular Degeneration; Macular Edema; Ocular Hypotension; Ophthalmia, Sympathetic; Papilledema; Photochemotherapy; Retinal Diseases; Retinal Neovascularization; Retinal Vein Occlusion; Time Factors; Triamcinolone Acetonide; Uveitis; Visual Acuity; Vitreous Body	2004
Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases. Acta ophthalmologica Scandinavica, 2005, Volume: 83, Issue:6 Topics: Choroidal Neovascularization; Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Macular Edema; Ocular Hypertension; Triamcinolone Acetonide; Vitreous Body	2005
Perspectives on verteporfin therapy combined with intravitreal corticosteroids. Archives of ophthalmology (Chicago, Ill. : 1960), 2006, Volume: 124, Issue:4 Topics: Choroidal Neovascularization; Combined Modality Therapy; Glucocorticoids; Humans; Injections; Macular Degeneration; Photochemotherapy; Photosensitizing Agents; Porphyrins; Triamcinolone Acetonide; Verteporfin; Vitreous Body	2006
Should corticosteroids be considered as part of the standard care with photodynamic therapy? Archives of ophthalmology (Chicago, Ill. : 1960), 2006, Volume: 124, Issue:4 Topics: Choroidal Neovascularization; Combined Modality Therapy; Delivery of Health Care; Glucocorticoids; Humans; Injections; Macular Degeneration; Photochemotherapy; Photosensitizing Agents; Porphyrins; Triamcinolone Acetonide; Verteporfin; Vitreous Body	2006
Drugs for some common eye disorders. Treatment guidelines from the Medical Letter, 2007, Volume: 5, Issue:53 Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Angiogenesis Inhibitors; Anti-Bacterial Agents; Antioxidants; Carbonic Anhydrase Inhibitors; Cholinergic Agonists; Conjunctivitis, Allergic; Conjunctivitis, Bacterial; Cyclosporine; Diuretics, Osmotic; Dry Eye Syndromes; Eye Diseases; Glaucoma; Glucocorticoids; Humans; Immunosuppressive Agents; Macular Degeneration; Ophthalmic Solutions; Patient Compliance; Patient Selection; Photochemotherapy; Prostaglandins; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Zinc	2007
[Age-related macular degeneration (AMD): etiopathogenesis and therapeutic strategies]. Postepy higieny i medycyny doswiadczalnej (Online), 2007, Volume: 61 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antioxidants; Aptamers, Nucleotide; Bevacizumab; Humans; Lipofuscin; Macular Degeneration; Neovascularization, Pathologic; Photochemotherapy; Pregnadienediols; Ranibizumab; Retinal Drusen; Triamcinolone Acetonide	2007
Surgical implantation of steroids with antiangiogenic characteristics for treating neovascular age-related macular degeneration. The Cochrane database of systematic reviews, 2007, Oct-17, Issue:4 Topics: Angiogenesis Inhibitors; Choroidal Neovascularization; Drug Implants; Humans; Macular Degeneration; Pregnadienediols; Randomized Controlled Trials as Topic; Triamcinolone Acetonide	2007

Trials

31 trial(s) available for triamcinolone acetonide and Macular Degeneration

Article	Year
Impact of intravitreal triamcinolone acetonide versus intravitreal bevacizumab on retrobulbar hemodynamic in patients with diabetic macular edema. Cutaneous and ocular toxicology, 2014, Volume: 33, Issue:1 Topics: Aged; Angiography; Antibodies, Monoclonal, Humanized; Bevacizumab; Blood Flow Velocity; Diabetic Retinopathy; Female; Hemodynamics; Humans; Intraocular Pressure; Intravitreal Injections; Macular Degeneration; Male; Middle Aged; Prospective Studies; Tomography, Optical Coherence; Tonometry, Ocular; Treatment Outcome; Triamcinolone Acetonide; Ultrasonography, Doppler, Color	2014
Reduced fluence versus standard photodynamic therapy in combination with intravitreal triamcinolone: short-term results of a randomised study. The British journal of ophthalmology, 2008, Volume: 92, Issue:10 Topics: Aged; Choroidal Neovascularization; Combined Modality Therapy; Dose-Response Relationship, Drug; Epidemiologic Methods; Female; Fluorescein Angiography; Glucocorticoids; Humans; Macular Degeneration; Male; Photochemotherapy; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity	2008
Intravitreal bevacizumab versus triamcinolone acetonide for exudative age-related macular degeneration. Ophthalmic research, 2009, Volume: 41, Issue:1 Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Chi-Square Distribution; Female; Follow-Up Studies; Humans; Injections, Intralesional; Intraocular Pressure; Macular Degeneration; Male; Retrospective Studies; Triamcinolone Acetonide; Visual Acuity	2009
Combination of photodynamic therapy and intraocular triamcinolone for exudative age-related macular degeneration and long-term chorioretinal macular atrophy. Archives of ophthalmology (Chicago, Ill. : 1960), 2008, Volume: 126, Issue:10 Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Atrophy; Choroidal Neovascularization; Chronic Disease; Combined Modality Therapy; Drug Administration Routes; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Prospective Studies; Retina; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body	2008
Photodynamic therapy and intravitreal triamcinolone for neovascular age-related macular degeneration: a randomized clinical trial. Ophthalmology, 2009, Volume: 116, Issue:11 Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Double-Blind Method; Drug Therapy, Combination; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body	2009
Efficacy of combined photodynamic therapy and sub-Tenon's capsule injection of triamcinolone acetonide for age-related macular degeneration. The journal of medical investigation : JMI, 2009, Volume: 56, Issue:3-4 Topics: Aged; Anti-Inflammatory Agents; Combined Modality Therapy; Connective Tissue; Female; Humans; Macular Degeneration; Male; Photochemotherapy; Photosensitizing Agents; Porphyrins; Triamcinolone Acetonide; Verteporfin; Visual Acuity	2009
Changes in macular sensitivity after reduced fluence photodynamic therapy combined with intravitreal triamcinolone. Acta ophthalmologica, 2011, Volume: 89, Issue:2 Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Combined Modality Therapy; Contrast Sensitivity; Double-Blind Method; Fluorescein Angiography; Glucocorticoids; Humans; Intravitreal Injections; Macular Degeneration; Middle Aged; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Porphyrins; Prospective Studies; Retina; Treatment Outcome; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Visual Field Tests	2011
Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials. Archives of ophthalmology (Chicago, Ill. : 1960), 2009, Volume: 127, Issue:12 Topics: Anesthetics, Local; Angiogenesis Inhibitors; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Disinfection; Endophthalmitis; Eye Infections, Bacterial; Glucocorticoids; Humans; Incidence; Injections; Laser Coagulation; Macular Degeneration; Methicillin-Resistant Staphylococcus aureus; Povidone-Iodine; Prospective Studies; Ranibizumab; Risk Factors; Staphylococcal Infections; Streptococcal Infections; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Viridans Streptococci; Vitreous Body	2009
[Triple therapy for the treatment of choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration]. Journal francais d'ophtalmologie, 2010, Volume: 33, Issue:7 Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Choroidal Neovascularization; Combined Modality Therapy; Female; Humans; Intravitreal Injections; Macular Degeneration; Male; Photochemotherapy; Prospective Studies; Ranibizumab; Retinal Detachment; Triamcinolone Acetonide	2010
A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results. Archives of ophthalmology (Chicago, Ill. : 1960), 2003, Volume: 121, Issue:5 Topics: Aged; Choroidal Neovascularization; Double-Blind Method; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Male; Prospective Studies; Safety; Triamcinolone Acetonide; Vision Disorders; Visual Acuity; Vitreous Body	2003
Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization. Ophthalmology, 2003, Volume: 110, Issue:8 Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Choroidal Neovascularization; Drug Therapy, Combination; Female; Fluorescein Angiography; Humans; Injections; Macular Degeneration; Male; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Porphyrins; Prospective Studies; Treatment Outcome; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body	2003
Intravitreal reinjection of triamcinolone for exudative age-related macular degeneration. Archives of ophthalmology (Chicago, Ill. : 1960), 2004, Volume: 122, Issue:2 Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Exudates and Transudates; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Male; Middle Aged; Prospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body	2004
Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial. Archives of ophthalmology (Chicago, Ill. : 1960), 2004, Volume: 122, Issue:3 Topics: Aged; Aged, 80 and over; Cataract; Choroidal Neovascularization; Double-Blind Method; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Male; Middle Aged; Prospective Studies; Safety; Triamcinolone Acetonide; Visual Acuity; Vitreous Body	2004
Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative nonrandomized study. Eye (London, England), 2005, Volume: 19, Issue:2 Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Disease Progression; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections, Intralesional; Intraocular Pressure; Macular Degeneration; Male; Prospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body	2005
Intravitreal triamcinolone-induced elevated intraocular pressure is associated with the development of posterior subcapsular cataract. Ophthalmology, 2005, Volume: 112, Issue:1 Topics: Aged; Cataract; Double-Blind Method; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Intraocular Pressure; Lens, Crystalline; Macular Degeneration; Male; Tonometry, Ocular; Triamcinolone Acetonide; Vitreous Body	2005
Diffuse diabetic macular oedema treated by intravitreal triamcinolone acetonide: a comparative, non-randomised study. The British journal of ophthalmology, 2005, Volume: 89, Issue:3 Topics: Aged; Anti-Inflammatory Agents; Chi-Square Distribution; Diabetes Mellitus; Female; Follow-Up Studies; Humans; Injections; Laser Therapy; Macular Degeneration; Male; Middle Aged; Prospective Studies; Statistics, Nonparametric; Triamcinolone Acetonide; Visual Acuity; Vitreous Body	2005
Indocyanine green-mediated photothrombosis with intravitreal triamcinolone acetonide for subfoveal choroidal neovascularization in age-related macular degeneration. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2005, Volume: 243, Issue:11 Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Coloring Agents; Combined Modality Therapy; Female; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Injections; Lasers; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body	2005
Intereye difference in exudative age-related macular degeneration with minimally classic or occult subfoveal neovascularization after unilateral intravitreal injection of triamcinolone acetonide. American journal of ophthalmology, 2005, Volume: 139, Issue:6 Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Exudates and Transudates; Female; Fovea Centralis; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Male; Middle Aged; Triamcinolone Acetonide; Visual Acuity; Vitreous Body	2005
Indocyanine green-mediated photothrombosis with and without intravitreal triamcinolone acetonide for subfoveal choroidal neovascularization in age-related macular degeneration: a pilot study. Retina (Philadelphia, Pa.), 2005, Volume: 25, Issue:6 Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Coloring Agents; Combined Modality Therapy; Embolization, Therapeutic; Feasibility Studies; Female; Fluorescein Angiography; Fovea Centralis; Glucocorticoids; Humans; Indocyanine Green; Injections; Macular Degeneration; Male; Middle Aged; Pilot Projects; Prospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body	2005
Comparison of ICG-assisted ILM peeling and triamcinolone-assisted posterior vitreous removal in diffuse diabetic macular oedema. Eye (London, England), 2006, Volume: 20, Issue:12 Topics: Diabetes Mellitus, Type 2; Diabetic Retinopathy; Epiretinal Membrane; Female; Follow-Up Studies; Glucocorticoids; Humans; Indocyanine Green; Light Coagulation; Macular Degeneration; Male; Middle Aged; Retrospective Studies; Statistics, Nonparametric; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitrectomy	2006
Intravitreal triamcinolone with transpupillary therapy for subfoveal choroidal neovascularization in age related macular degeneration. A randomized controlled pilot study [ISRCTN74123635]. BMC ophthalmology, 2005, Nov-25, Volume: 5 Topics: Aged; Choroidal Neovascularization; Combined Modality Therapy; Glucocorticoids; Humans; Hyperthermia, Induced; Injections; Macular Degeneration; Pilot Projects; Prospective Studies; Pupil; Triamcinolone Acetonide; Visual Acuity; Vitreous Body	2005
The use of subretinal triamcinolone acetonide in the management of neovascular age-related macular degeneration: a pilot study. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2005, Volume: 40, Issue:5 Topics: Choroidal Neovascularization; Combined Modality Therapy; Electroretinography; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Injections; Macular Degeneration; Pilot Projects; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitrectomy	2005
Macular atrophy after combined intravitreal triamcinolone acetonide (IVTA) and photodynamic therapy (PDT) for retinal angiomatous proliferation (RAP). Klinische Monatsblatter fur Augenheilkunde, 2006, Volume: 223, Issue:5 Topics: Aged; Angiomatosis; Anti-Inflammatory Agents; Combined Modality Therapy; Drug Combinations; Female; Humans; Injections; Macular Degeneration; Male; Photochemotherapy; Prospective Studies; Retinal Neovascularization; Risk Assessment; Risk Factors; Treatment Failure; Treatment Outcome; Triamcinolone Acetonide	2006
Photodynamic therapy with intravitreal triamcinolone in predominantly classic choroidal neovascularization: one-year results of a randomized study. Ophthalmology, 2006, Volume: 113, Issue:12 Topics: Aged; Choroidal Neovascularization; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Degeneration; Male; Photochemotherapy; Photosensitizing Agents; Porphyrins; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body	2006
Visual acuity change after intravitreal triamcinolone in various types of exudative age-related macular degeneration. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2006, Volume: 22, Issue:5 Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Humans; Injections; Intraocular Pressure; Macular Degeneration; Middle Aged; Time Factors; Triamcinolone Acetonide; Visual Acuity; Vitreous Body	2006
Optical coherence tomography analysis of a randomized study combining photodynamic therapy with intravitreal triamcinolone. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2008, Volume: 246, Issue:2 Topics: Choroidal Neovascularization; Drug Therapy, Combination; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macular Degeneration; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body	2008
Periocular triamcinolone and photodynamic therapy for subfoveal choroidal neovascularization in age-related macular degeneration. Ophthalmology, 2007, Volume: 114, Issue:9 Topics: Aged; Capillary Permeability; Choroidal Neovascularization; Female; Fluorescein; Fluorescein Angiography; Fluorescent Dyes; Fovea Centralis; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Male; Photochemotherapy; Photosensitizing Agents; Porphyrins; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body	2007
Triamcinolone acetonide as adjunctive treatment to verteporfin in neovascular age-related macular degeneration: a prospective randomized trial. Ophthalmology, 2007, Volume: 114, Issue:12 Topics: Aged; Aged, 80 and over; Cataract; Chemotherapy, Adjuvant; Choroidal Neovascularization; Contrast Sensitivity; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Male; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Porphyrins; Prospective Studies; Retina; Retreatment; Tomography, Optical Coherence; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body	2007
Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up. Australian and New Zealand journal of ophthalmology, 1998, Volume: 26, Issue:4 Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Exudates and Transudates; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Male; Safety; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body	1998
Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina (Philadelphia, Pa.), 2000, Volume: 20, Issue:3 Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Choroidal Neovascularization; Female; Fluorescein Angiography; Humans; Injections; Intraocular Pressure; Macular Degeneration; Male; Middle Aged; Pilot Projects; Triamcinolone Acetonide; Visual Acuity; Vitreous Body	2000
Exudative macular degeneration and intravitreal triamcinolone. A pilot study. Australian and New Zealand journal of ophthalmology, 1995, Volume: 23, Issue:4 Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Case-Control Studies; Choroidal Neovascularization; Exudates and Transudates; Female; Fluorescein Angiography; Humans; Injections; Macular Degeneration; Male; Pilot Projects; Prospective Studies; Safety; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body	1995

Other Studies

100 other study(ies) available for triamcinolone acetonide and Macular Degeneration

Article	Year
Two-year clinical outcomes of triple therapy with photodynamic therapy, anti-vascular endothelial growth factor agent, and triamcinolone acetonide for neovascular age-related macular degeneration. Japanese journal of ophthalmology, 2023, Volume: 67, Issue:1 Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Humans; Intravitreal Injections; Macular Degeneration; Middle Aged; Photochemotherapy; Ranibizumab; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factors	2023
Ziv-aflibercept combined with intravitreal steroid for management of peripheral exudative haemorrhagic chorioretinopathy. BMJ case reports, 2019, Sep-11, Volume: 12, Issue:9 Topics: Aged; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Intravitreal Injections; Macular Degeneration; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Retinal Hemorrhage; Triamcinolone Acetonide	2019
Synthesis and Characterisation of Photocrosslinked poly(ethylene glycol) diacrylate Implants for Sustained Ocular Drug Delivery. Pharmaceutical research, 2018, Jan-16, Volume: 35, Issue:2 Topics: Administration, Ophthalmic; Biological Products; Cell Line; Diabetic Retinopathy; Drug Compounding; Drug Delivery Systems; Drug Implants; Drug Liberation; Glucocorticoids; Humans; Macular Degeneration; Materials Testing; Molecular Weight; Ovalbumin; Polyethylene Glycols; Porosity; Retinal Pigment Epithelium; Triamcinolone Acetonide	2018
Particle-induced endophthalmitis: possible mechanisms of sterile endophthalmitis after intravitreal triamcinolone. Investigative ophthalmology & visual science, 2013, Mar-11, Volume: 54, Issue:3 Topics: Aqueous Humor; Cells, Cultured; Cytokines; Diabetic Retinopathy; Endophthalmitis; Epithelial Cells; Glucocorticoids; Granulocytes; Granuloma, Foreign-Body; Humans; Intravitreal Injections; Lens, Crystalline; Macular Degeneration; Retinal Pigment Epithelium; Retinal Vein Occlusion; Triamcinolone Acetonide	2013
Objective area measurement technique for choroidal neovascularization from fluorescein angiography. Microvascular research, 2014, Volume: 91 Topics: Animals; Bruch Membrane; Choroidal Neovascularization; Dexamethasone; Fluorescein; Fluorescein Angiography; Humans; Hydrogels; Image Processing, Computer-Assisted; Intravitreal Injections; Lasers; Macular Degeneration; Male; Nanospheres; Rats; Rats, Long-Evans; Triamcinolone Acetonide	2014
Triamcinolone acetonide nanoparticles incorporated in thermoreversible gels for age-related macular degeneration. Pharmaceutical development and technology, 2016, Volume: 21, Issue:1 Topics: Cell Line; Dose-Response Relationship, Drug; Drug Delivery Systems; Gels; Humans; Macular Degeneration; Nanoparticles; Polyethylene Glycols; Polyglactin 910; Retinal Pigment Epithelium; Temperature; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A	2016
ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION: Role of Prophylactic Topical Ophthalmic Antibiotics. Retina (Philadelphia, Pa.), 2016, Volume: 36, Issue:7 Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteria; Diabetic Retinopathy; Endophthalmitis; Eye Infections, Bacterial; Female; Humans; Incidence; Intravitreal Injections; Macular Degeneration; Macular Edema; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Risk Factors; Triamcinolone Acetonide; Vitreous Body	2016
Combination treatment with reduced-fluence photodynamic therapy and intravitreal injection of triamcinolone for subfoveal choroidal neovascularization in macular degeneration. Retina (Philadelphia, Pa.), 2008, Volume: 28, Issue:6 Topics: Choroidal Neovascularization; Combined Modality Therapy; Dose-Response Relationship, Drug; Glucocorticoids; Humans; Injections; Macular Degeneration; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body	2008
Photodynamic therapy with intravitreal application of triamcinolone acetonide in age-related macular degeneration: functional results in 54 patients. Acta ophthalmologica, 2009, Volume: 87, Issue:2 Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Choroidal Neovascularization; Drug Synergism; Female; Humans; Injections; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body	2009
Bevacizumab treatment for subfoveal choroidal neovascularization from causes other than age-related macular degeneration. Archives of ophthalmology (Chicago, Ill. : 1960), 2008, Volume: 126, Issue:7 Topics: Adult; Angiogenesis Inhibitors; Angioid Streaks; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroidal Neovascularization; Choroiditis; Drug Therapy, Combination; Female; Follow-Up Studies; Fovea Centralis; Humans; Injections; Macular Degeneration; Male; Middle Aged; Myopia, Degenerative; Photochemotherapy; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body	2008
Photodynamic therapy combined with low-dose intravitreal triamcinolone acetonide for age-related macular degeneration refractory to photodynamic therapy alone. The British journal of ophthalmology, 2008, Volume: 92, Issue:10 Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Fluorescein Angiography; Glucocorticoids; Humans; Intraocular Pressure; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Porphyrins; Retreatment; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Verteporfin; Visual Acuity	2008
Is there tachyphylaxis to intravitreal anti-vascular endothelial growth factor pharmacotherapy in age-related macular degeneration? Ophthalmology, 2008, Volume: 115, Issue:12 Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Drug Therapy, Combination; Exudates and Transudates; Female; Humans; Injections; Macular Degeneration; Male; Retina; Retreatment; Retrospective Studies; Tachyphylaxis; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vitreous Body	2008
Efficacy of intravitreal and periocular triamcinolone associated with photodynamic therapy for treatment of retinal angiomatous proliferation. The British journal of ophthalmology, 2009, Volume: 93, Issue:2 Topics: Aged; Aged, 80 and over; Drug Evaluation; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Injections; Macular Degeneration; Male; Orbit; Photochemotherapy; Retinal Neovascularization; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body	2009
[Intravitreous injection: retrospective study on 2028 injections and their side effects]. Journal francais d'ophtalmologie, 2008, Volume: 31, Issue:7 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Cataract; Diabetic Retinopathy; Endophthalmitis; Epiretinal Membrane; Humans; Injections; Macular Degeneration; Macular Edema; Ocular Hypertension; Ranibizumab; Retinal Detachment; Retinal Perforations; Retinal Vein Occlusion; Retrospective Studies; Risk Assessment; Triamcinolone Acetonide; Vitreous Body; Vitreous Hemorrhage	2008
Time-course and characteristic morphology of retinal changes following combination of verteporfin therapy and intravitreal triamcinolone in neovascular age-related macular degeneration. Acta ophthalmologica, 2010, Volume: 88, Issue:2 Topics: Choroidal Neovascularization; Combined Modality Therapy; Exudates and Transudates; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macular Degeneration; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retina; Retrospective Studies; Time Factors; Tomography, Optical Coherence; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body	2010
[Evaluation of visual function among patients with exudative AMD treated with an intravitreal injection of triamcinolone acetonide]. Annales Academiae Medicae Stetinensis, 2008, Volume: 54, Issue:1 Topics: Anti-Inflammatory Agents; Choroidal Neovascularization; Fluorescein Angiography; Humans; Macular Degeneration; Retinal Neovascularization; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity	2008
Secondary elevated IOP and cataracts after high-dose intravitreal triamcinolone and photodynamic therapy to treat choroidal neovascularization. Journal of glaucoma, 2009, Volume: 18, Issue:1 Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Cataract; Cataract Extraction; Choroidal Neovascularization; Combined Modality Therapy; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Male; Middle Aged; Ocular Hypertension; Photochemotherapy; Retrospective Studies; Triamcinolone Acetonide; Vitreous Body	2009
Economic implications of current age-related macular degeneration treatments. Ophthalmology, 2009, Volume: 116, Issue:3 Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Combined Modality Therapy; Cost-Benefit Analysis; Drug Therapy, Combination; Glucocorticoids; Health Care Costs; Humans; Macular Degeneration; Models, Economic; Photochemotherapy; Ranibizumab; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vision Disorders; Visual Acuity	2009
Serous pigment epithelial detachment in age-related macular degeneration: comparison of different treatments. Eye (London, England), 2009, Volume: 23, Issue:12 Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Female; Fluorescein Angiography; Follow-Up Studies; Fovea Centralis; Humans; Immunologic Factors; Intravitreal Injections; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Pigment Epithelium of Eye; Ranibizumab; Retinal Detachment; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity	2009
Focal macular electroretinograms after photodynamic therapy combined with posterior juxtascleral triamcinolone acetonide. Retina (Philadelphia, Pa.), 2009, Volume: 29, Issue:6 Topics: Aged; Choroidal Neovascularization; Coloring Agents; Combined Modality Therapy; Electroretinography; Female; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Injections; Macula Lutea; Macular Degeneration; Male; Photochemotherapy; Photosensitizing Agents; Porphyrins; Sclera; Tomography, Optical Coherence; Triamcinolone Acetonide; Verteporfin	2009
Early effects of intravitreal triamcinolone acetonide on inflammation and proliferation in human choroidal neovascularization. Archives of ophthalmology (Chicago, Ill. : 1960), 2009, Volume: 127, Issue:3 Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Choroidal Neovascularization; Combined Modality Therapy; E-Selectin; Female; Humans; Immunoenzyme Techniques; Inflammation; Injections; Intercellular Adhesion Molecule-1; Laser Coagulation; Leukocyte Common Antigens; Leukocyte Count; Leukocytes; Lymphocyte Activation; Macrophages; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Retina; Retrospective Studies; Thy-1 Antigens; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vitreous Body	2009
Bilateral simultaneous intravitreal injections in the office setting. American journal of ophthalmology, 2009, Volume: 148, Issue:1 Topics: Aged; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroidal Neovascularization; Dexamethasone; Diabetic Retinopathy; Drug Therapy, Combination; Functional Laterality; Humans; Injections; Intraoperative Complications; Macular Degeneration; Macular Edema; Office Visits; Postoperative Complications; Ranibizumab; Retinal Vein Occlusion; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body	2009
Bevacizumab tachyphylaxis. Ophthalmology, 2009, Volume: 116, Issue:5 Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Drug Therapy, Combination; Exudates and Transudates; Humans; Injections; Macular Degeneration; Retina; Retreatment; Retrospective Studies; Tachyphylaxis; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vitreous Body	2009
Combined intravitreal bevacizumab and triamcinolone in exudative age-related macular degeneration. Acta ophthalmologica, 2010, Volume: 88, Issue:6 Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Drug Therapy, Combination; Exudates and Transudates; Female; Fluorescein Angiography; Glucocorticoids; Humans; Intravitreal Injections; Macular Degeneration; Male; Retina; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity	2010
Tachyphylaxis and bevacizumab. Ophthalmology, 2009, Volume: 116, Issue:8 Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Drug Therapy, Combination; Exudates and Transudates; Humans; Injections; Macular Degeneration; Retina; Retreatment; Tachyphylaxis; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vitreous Body	2009
Tachyphylaxis and bevacizumab. Ophthalmology, 2009, Volume: 116, Issue:9 Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Drug Therapy, Combination; Exudates and Transudates; Humans; Injections; Macular Degeneration; Retina; Retreatment; Tachyphylaxis; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vitreous Body	2009
Effect of combined treatment with sub-Tenon injection of triamcinolone acetonide and photodynamic therapy in Japanese patients with age-related macular degeneration. Japanese journal of ophthalmology, 2009, Volume: 53, Issue:5 Topics: Aged; Asian People; Combined Modality Therapy; Connective Tissue; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Japan; Macular Degeneration; Male; Photochemotherapy; Retreatment; Retrospective Studies; Risk Assessment; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity	2009
Effect of photodynamic therapy alone or combined with posterior subtenon triamcinolone acetonide or intravitreal bevacizumab on choroidal hypofluorescence by indocyanine green angiography. Retina (Philadelphia, Pa.), 2010, Volume: 30, Issue:3 Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroid; Choroidal Neovascularization; Coloring Agents; Drug Therapy, Combination; Female; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Injections; Macular Degeneration; Male; Photochemotherapy; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body	2010
Intravitreal injection of triamcinolone combined with bevacizumab for choroidal neovascularization associated with large retinal pigment epithelial detachment in age-related macular degeneration. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2010, Volume: 248, Issue:6 Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroidal Neovascularization; Coloring Agents; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Indocyanine Green; Injections; Macular Degeneration; Male; Middle Aged; Prognosis; Prospective Studies; Retinal Detachment; Retinal Pigment Epithelium; Retreatment; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body	2010
Toxic vitreitis outbreak after intravitreal injection. Retina (Philadelphia, Pa.), 2010, Volume: 30, Issue:2 Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Disease Outbreaks; Eye Diseases; Female; Humans; Injections; Macular Degeneration; Macular Edema; Male; Ranibizumab; Retinal Hemorrhage; Retrospective Studies; Suppuration; Syringes; Triamcinolone Acetonide; Vitreous Body	2010
Cytomegalovirus retinitis after subtenon triamcinolone acetonide and intravitreal injection of anti-vascular endothelial growth factor in an immunocompetent patient with age-related macular degeneration and diabetes mellitus. Japanese journal of ophthalmology, 2010, Volume: 54, Issue:2 Topics: Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroidal Neovascularization; Cytomegalovirus Retinitis; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Fascia; Glucocorticoids; Humans; Immunocompromised Host; Injections; Macular Degeneration; Male; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vitrectomy; Vitreous Body	2010
Intravitreal bevacizumab combined with intravitreal triamcinolone for therapy-resistant exudative age-related macular degeneration. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2010, Volume: 26, Issue:2 Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Drug Resistance; Drug Therapy, Combination; Exudates and Transudates; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Male; Middle Aged; Prospective Studies; Retina; Retreatment; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body	2010
Inhibition of choroidal neovascularization by intravitreal ketorolac. Archives of ophthalmology (Chicago, Ill. : 1960), 2010, Volume: 128, Issue:5 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Capillary Permeability; Choroidal Neovascularization; Disease Models, Animal; Fluorescein Angiography; Glucocorticoids; Injections; Ketorolac; Macular Degeneration; Male; Rats; Rats, Inbred BN; Triamcinolone Acetonide; Vitreous Body	2010
Intravitreal triamcinolone, bevacizumab and pegaptanib for occult choroidal neovascularization. Acta ophthalmologica, 2010, Volume: 88, Issue:8 Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Choroidal Neovascularization; Female; Fluorescein Angiography; Follow-Up Studies; Fovea Centralis; Glucocorticoids; Humans; Intraocular Pressure; Intravitreal Injections; Macular Degeneration; Male; Prognosis; Retreatment; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity	2010
Color Doppler imaging of ocular blood flow after combined photodynamic therapy with intravitreal triamcinolone in age-related macular degeneration. Current eye research, 2011, Volume: 36, Issue:2 Topics: Aged; Aged, 80 and over; Blood Flow Velocity; Choroidal Neovascularization; Ciliary Arteries; Combined Modality Therapy; Female; Glucocorticoids; Humans; Intravitreal Injections; Macular Degeneration; Male; Middle Aged; Ophthalmic Artery; Photochemotherapy; Photosensitizing Agents; Porphyrins; Regional Blood Flow; Retinal Artery; Triamcinolone Acetonide; Ultrasonography, Doppler, Color; Verteporfin; Visual Acuity	2011
A retrospective analysis of triple combination therapy with intravitreal bevacizumab, posterior sub-tenon's triamcinolone acetonide, and low-fluence verteporfin photodynamic therapy in patients with neovascular age-related macular degeneration. Retina (Philadelphia, Pa.), 2011, Volume: 31, Issue:3 Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Combined Modality Therapy; Drug Therapy, Combination; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Macular Degeneration; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retreatment; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Verteporfin; Visual Acuity	2011
Transpupillary thermotherapy (TTT) with injections of triamcinolone acetonide under posterior Tenon's capsule in the treatment of exudative age-related macular degeneration (AMD). Klinika oczna, 2010, Volume: 112, Issue:10-12 Topics: Aged; Aged, 80 and over; Combined Modality Therapy; Female; Glucocorticoids; Humans; Hyperthermia, Induced; Intravitreal Injections; Macular Degeneration; Male; Middle Aged; Poland; Tenon Capsule; Triamcinolone Acetonide; Visual Acuity	2010
[Serum antiretinal antibodies (ARA) in patients with exudative age-related macular degeneration (AMD) treated with transpupillary thermotherapy (TTT) alone and with transpupillary thermotherapy (TTT) combined with injection of triamcinolone acetonide (sTT Klinika oczna, 2011, Volume: 113, Issue:1-3 Topics: Aged; Aged, 80 and over; Autoantibodies; Combined Modality Therapy; Female; Fluorescent Antibody Technique, Indirect; Follow-Up Studies; Humans; Hyperthermia, Induced; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Intravitreal Injections; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Poland; Prospective Studies; Retina; Tenon Capsule; Triamcinolone Acetonide	2011
[Complications of intravitreal injections--own experience]. Klinika oczna, 2011, Volume: 113, Issue:4-6 Topics: Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Conjunctival Diseases; Diabetic Retinopathy; Endophthalmitis; Eye Diseases; Eye Hemorrhage; Female; Follow-Up Studies; Glucocorticoids; Humans; Inflammation; Intravitreal Injections; Iris Diseases; Macular Degeneration; Macular Edema; Male; Middle Aged; Ocular Hypertension; Poland; Ranibizumab; Retinal Diseases; Retinal Vein Occlusion; Retrospective Studies; Risk Factors; Triamcinolone Acetonide; Visual Acuity	2011
Vitreous pharmacokinetics and retinal safety of intravitreal preserved versus non-preserved triamcinolone acetonide in rabbit eyes. Current eye research, 2012, Volume: 37, Issue:1 Topics: Animals; Chromatography, High Pressure Liquid; Disease Models, Animal; Dose-Response Relationship, Drug; Electroretinography; Intravitreal Injections; Macular Degeneration; Male; Rabbits; Retina; Triamcinolone Acetonide; Vitreous Body	2012
Vascularized retinal pigment epithelial detachment in age-related macular degeneration: treatment and RPE tear incidence. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2012, Volume: 250, Issue:9 Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroidal Neovascularization; Combined Modality Therapy; Female; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Intravitreal Injections; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Ranibizumab; Retinal Detachment; Retinal Neovascularization; Retinal Perforations; Retinal Pigment Epithelium; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Verteporfin; Visual Acuity	2012
Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections. Ophthalmology, 2012, Volume: 119, Issue:8 Topics: Aged; Aged, 80 and over; Anesthetics, Local; Angiogenesis Inhibitors; Anti-Bacterial Agents; Antibiotic Prophylaxis; Diabetic Retinopathy; Endophthalmitis; Female; Fluoroquinolones; Glucocorticoids; Humans; Incidence; Intravitreal Injections; Macular Degeneration; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Risk Factors; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity	2012
Photodynamic therapy combined with intravitreal bevacizumab and sub-tenon triamcinolone acetonide injections for age-related macular degeneration. Japanese journal of ophthalmology, 2013, Volume: 57, Issue:1 Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Humans; Injections; Intravitreal Injections; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Retrospective Studies; Tenon Capsule; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity	2013
Bevacizumab and triamcinolone acetonide for choroidal neovascularization due to age-related macular degeneration unresponsive to antivascular endothelial growth factors. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2013, Volume: 29, Issue:4 Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Bevacizumab; Choroidal Neovascularization; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Intravitreal Injections; Macular Degeneration; Male; Middle Aged; Retrospective Studies; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity	2013
Intraocular pressure after intravitreal injection of triamcinolone acetonide. The British journal of ophthalmology, 2003, Volume: 87, Issue:1 Topics: Aged; Anti-Inflammatory Agents; Female; Humans; Injections; Intraocular Pressure; Macular Degeneration; Macular Edema; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Triamcinolone Acetonide; Vitreous Body	2003
Repeated intravitreal injections of triamcinolone acetonide as treatment of progressive exudative age-related macular degeneration. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2002, Volume: 240, Issue:10 Topics: Aged; Drug Administration Schedule; Female; Glucocorticoids; Humans; Injections; Macular Degeneration; Triamcinolone Acetonide; Vitreous Body	2002
Intravitreal triamcinolone acetonide for exudative age related macular degeneration. The British journal of ophthalmology, 2003, Volume: 87, Issue:4 Topics: Aged; Aged, 80 and over; Cataract; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Male; Middle Aged; Prospective Studies; Time Factors; Triamcinolone Acetonide; Visual Acuity	2003
Intravitreal triamcinolone with photodynamic therapy for subfoveal choroidal neovascularisation in age related macular degeneration. The British journal of ophthalmology, 2004, Volume: 88, Issue:3 Topics: Aged; Aged, 80 and over; Choroid; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Degeneration; Male; Neovascularization, Pathologic; Photochemotherapy; Retrospective Studies; Triamcinolone Acetonide	2004
Intraocular availability of triamcinolone acetonide after intravitreal injection. American journal of ophthalmology, 2004, Volume: 137, Issue:3 Topics: Aqueous Humor; Biological Availability; Chromatography, High Pressure Liquid; Female; Gas Chromatography-Mass Spectrometry; Glucocorticoids; Humans; Injections; Macular Degeneration; Macular Edema; Male; Prospective Studies; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitreous Body	2004
Intravitreal triamcinolone acetonide for exudative age related macular degeneration. The British journal of ophthalmology, 2004, Volume: 88, Issue:4 Topics: Aged; Data Interpretation, Statistical; Glucocorticoids; Humans; Injections; Macular Degeneration; Treatment Outcome; Triamcinolone Acetonide; Vitreous Body	2004
Cataract surgery after intravitreal injection of triamcinolone acetonide. Eye (London, England), 2004, Volume: 18, Issue:4 Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Cataract; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Macular Degeneration; Macular Edema; Male; Middle Aged; Phacoemulsification; Prospective Studies; Triamcinolone Acetonide; Visual Acuity	2004
Morphallaxia-like ocular histology after intravitreal triamcinolone acetonide. The British journal of ophthalmology, 2004, Volume: 88, Issue:6 Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Eye; Female; Granulocytes; Humans; Injections, Intralesional; Macular Degeneration; Triamcinolone Acetonide	2004
Serum levels of triamcinolone acetonide after intravitreal injection. American journal of ophthalmology, 2004, Volume: 137, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Chromatography, High Pressure Liquid; Female; Glucocorticoids; Humans; Injections; Macular Degeneration; Macular Edema; Male; Middle Aged; Prospective Studies; Triamcinolone Acetonide; Vitreous Body	2004
Rinsing of the cannula prior to intravitreal injection. Archives of ophthalmology (Chicago, Ill. : 1960), 2004, Volume: 122, Issue:10 Topics: Catheterization; Humans; Immunosuppressive Agents; Macular Degeneration; Needles; Triamcinolone Acetonide; Vitreous Body	2004
Retinal angiomatous proliferation: clinical characteristics and treatment options. Optometry (St. Louis, Mo.), 2004, Volume: 75, Issue:9 Topics: Aged; Aged, 80 and over; Angiomatosis; Choroidal Neovascularization; Combined Modality Therapy; Female; Fluorescein Angiography; Humans; Indocyanine Green; Macular Degeneration; Photochemotherapy; Retinal Neovascularization; Tomography, Optical Coherence; Triamcinolone Acetonide	2004
Factors influencing visual acuity after intravitreal triamcinolone acetonide as treatment of exudative age related macular degeneration. The British journal of ophthalmology, 2004, Volume: 88, Issue:12 Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Female; Humans; Macula Lutea; Macular Degeneration; Male; Middle Aged; Neovascularization, Pathologic; Prospective Studies; Retinal Detachment; Triamcinolone Acetonide; Visual Acuity	2004
Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization. Ophthalmology, 2005, Volume: 112, Issue:2 Topics: Aged; Choroidal Neovascularization; Drug Therapy, Combination; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macular Degeneration; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Porphyrins; Prospective Studies; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body	2005
[Intravitreal triamcinolone therapy. New therapeutic alternative for patients with vision-threatening eye diseases]. Ugeskrift for laeger, 2005, Apr-18, Volume: 167, Issue:16 Topics: Contraindications; Glucocorticoids; Humans; Injections; Macular Degeneration; Triamcinolone Acetonide; Uveitis; Vitreous Body	2005
Intravitreous triamcinolone simulating frosted retinal angiitis. Retina (Philadelphia, Pa.), 2005, Volume: 25, Issue:4 Topics: Aged; Diagnosis, Differential; Female; Glucocorticoids; Humans; Injections; Macular Degeneration; Macular Edema; Male; Retinal Vasculitis; Retinal Vein Occlusion; Retinal Vessels; Triamcinolone Acetonide; Vitreous Body	2005
Severe loss of vision after removal of cataract caused by intravitreal triamcinolone in combination with photodynamic therapy for exudative age-related macular degeneration. Clinical & experimental ophthalmology, 2005, Volume: 33, Issue:5 Topics: Aged; Blindness; Cataract; Cataract Extraction; Drug Therapy, Combination; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macular Degeneration; Photochemotherapy; Photosensitizing Agents; Triamcinolone Acetonide; Visual Acuity; Vitreous Body	2005
Effect of posterior juxtascleral triamcinolone acetonide on choroidal neovascular growth after photodynamic therapy with verteporfin. Ophthalmology, 2005, Volume: 112, Issue:11 Topics: Aged; Aged, 80 and over; Chemotherapy, Adjuvant; Choroidal Neovascularization; Connective Tissue; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Sclera; Treatment Outcome; Triamcinolone Acetonide; Verteporfin; Visual Acuity	2005
A new treatment regimen in combined intravitreal injection of triamcinolone acetonide and photodynamic therapy. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2006, Volume: 244, Issue:7 Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Combined Modality Therapy; Female; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Injections; Macular Degeneration; Male; Photochemotherapy; Prospective Studies; Retinal Neovascularization; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body	2006
Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration. Ophthalmology, 2006, Volume: 113, Issue:1 Topics: Aged; Choroidal Neovascularization; Combined Modality Therapy; Drug Therapy, Combination; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macular Degeneration; Male; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retreatment; Treatment Outcome; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body	2006
Triamcinolone for occult exudative age-related macular degeneration. American journal of ophthalmology, 2006, Volume: 141, Issue:1 Topics: Exudates and Transudates; Glucocorticoids; Humans; Injections; Macular Degeneration; Retinal Neovascularization; Triamcinolone Acetonide; Vitreous Body	2006
Occult with no classic choroidal neovascularization secondary to age-related macular degeneration treated by intravitreal triamcinolone and photodynamic therapy with verteporfin. Retina (Philadelphia, Pa.), 2006, Volume: 26, Issue:1 Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Drug Therapy, Combination; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Prospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body	2006
Follow-up after intravitreal triamcinolone acetonide for exudative age-related macular degeneration. Eye (London, England), 2007, Volume: 21, Issue:3 Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Middle Aged; Prospective Studies; Time Factors; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body	2007
Retinal pigment epithelium tears following verteporfin therapy combined with intravitreal triamcinolone. American journal of ophthalmology, 2006, Volume: 141, Issue:2 Topics: Choroidal Neovascularization; Drug Therapy, Combination; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Macular Degeneration; Photochemotherapy; Photosensitizing Agents; Pigment Epithelium of Eye; Porphyrins; Prospective Studies; Retinal Perforations; Tomography, Optical Coherence; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body	2006
Infectious and noninfectious endophthalmitis after intravitreal high-dosage triamcinolone acetonide. American journal of ophthalmology, 2006, Volume: 141, Issue:3 Topics: Diabetic Retinopathy; Endophthalmitis; Glucocorticoids; Humans; Incidence; Injections; Macular Degeneration; Macular Edema; Preservatives, Pharmaceutical; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitreous Body	2006
Intravitreal triamcinolone acetonide for exudative age-related macular degeneration among Japanese patients. Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 2006, Volume: 220, Issue:2 Topics: Aged; Aged, 80 and over; Exudates and Transudates; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body	2006
Ptosis following an intravitreal injection of triamcinolone acetonide. Eye (London, England), 2007, Volume: 21, Issue:3 Topics: Aged; Blepharoptosis; Choroidal Neovascularization; Female; Glucocorticoids; Humans; Injections; Macular Degeneration; Male; Triamcinolone Acetonide; Vitreous Body	2007
Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration. American journal of ophthalmology, 2006, Volume: 141, Issue:4 Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Cataract Extraction; Choroidal Neovascularization; Drug Therapy, Combination; Female; Fluorescein Angiography; Glucocorticoids; Humans; Intraocular Pressure; Macular Degeneration; Male; Photochemotherapy; Photosensitizing Agents; Porphyrins; Prospective Studies; Retreatment; Treatment Outcome; Triamcinolone Acetonide; Verteporfin; Visual Acuity	2006
Remodeling of the vascular channels in retinal angiomatous proliferations treated with intravitreal triamcinolone acetonide and photodynamic therapy. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2006, Volume: 244, Issue:11 Topics: Aged; Aged, 80 and over; Coloring Agents; Drug Therapy, Combination; Female; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Injections; Macular Degeneration; Male; Photochemotherapy; Regional Blood Flow; Retinal Neovascularization; Retinal Vessels; Triamcinolone Acetonide; Vitreous Body	2006
Duration of the effect of intravitreal triamcinolone acetonide in eyes with exudative age-related macular degeneration. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2006, Volume: 22, Issue:3 Topics: Aged; Aged, 80 and over; Female; Humans; Injections; Intraocular Pressure; Macular Degeneration; Male; Middle Aged; Prospective Studies; Time Factors; Triamcinolone Acetonide; Visual Acuity; Vitreous Body	2006
Photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide in the treatment of neovascular age-related macular degeneration. American journal of ophthalmology, 2006, Volume: 142, Issue:1 Topics: Aged; Choroidal Neovascularization; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Degeneration; Male; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retreatment; Retrospective Studies; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body	2006
[Intravitreal application of triamcinolone--our experiences]. Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti, 2006, Volume: 60, Issue:2 Topics: Anti-Inflammatory Agents; Diabetic Retinopathy; Female; Glucocorticoids; Humans; Injections; Macular Degeneration; Male; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitreous Body	2006
[Medical and legal issues related to the drugs currently used in the treatment of Age-Related Macular Degeneration (ARMD)]. Archivos de la Sociedad Espanola de Oftalmologia, 2006, Volume: 81, Issue:7 Topics: Aptamers, Nucleotide; Drug Utilization; Humans; Macular Degeneration; Photosensitizing Agents; Porphyrins; Spain; Triamcinolone Acetonide; Verteporfin	2006
Evolving European guidance on the medical management of neovascular age related macular degeneration. The British journal of ophthalmology, 2006, Volume: 90, Issue:9 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Choroidal Neovascularization; Evidence-Based Medicine; Humans; Macular Degeneration; Photochemotherapy; Pregnadienediols; Ranibizumab; Treatment Outcome; Triamcinolone Acetonide	2006
Infectious and noninfectious endophthalmitis after intravitreal high-dosage triamcinolone acetonide. American journal of ophthalmology, 2006, Volume: 142, Issue:3 Topics: Diabetic Retinopathy; Endophthalmitis; Glucocorticoids; Humans; Incidence; Injections; Macular Degeneration; Macular Edema; Preservatives, Pharmaceutical; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitreous Body	2006
Inadvertent injection of triamcinolone into the crystalline lens. Eye (London, England), 2007, Volume: 21, Issue:1 Topics: Aged, 80 and over; Glucocorticoids; Humans; Injections; Lens, Crystalline; Macular Degeneration; Male; Medication Errors; Triamcinolone Acetonide	2007
Repeated intravitreal injection of triamcinolone for exudative age-related macular degeneration. Ophthalmic research, 2006, Volume: 38, Issue:6 Topics: Aged; Aged, 80 and over; Exudates and Transudates; Female; Glucocorticoids; Humans; Injections; Macular Degeneration; Male; Middle Aged; Retreatment; Triamcinolone Acetonide; Visual Acuity; Vitreous Body	2006
[Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration]. Journal francais d'ophtalmologie, 2007, Volume: 30, Issue:2 Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Choroid; Combined Modality Therapy; Female; Humans; Macular Degeneration; Male; Neovascularization, Pathologic; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retinal Detachment; Retrospective Studies; Triamcinolone Acetonide; Verteporfin	2007
Evaluation of subretinal triamcinolone acetonide in patients with exudative age-related macular degeneration. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2007, Volume: 23, Issue:1 Topics: Aged; Aging; Anti-Inflammatory Agents; Choroidal Neovascularization; Combined Modality Therapy; Electroretinography; Female; Fluorescein Angiography; Humans; Macular Degeneration; Male; Pilot Projects; Retina; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity	2007
Anatomical and visual outcome of retinal angiomatous proliferation treated with photodynamic therapy and intravitreal triamcinolone. American journal of ophthalmology, 2007, Volume: 143, Issue:4 Topics: Aged; Aged, 80 and over; Angiomatosis; Coloring Agents; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Indocyanine Green; Injections; Macular Degeneration; Male; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retinal Neovascularization; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body	2007
Intravitreal triamcinolone acetonide for serous retinal pigment epithelial detachments in exudative age-related macular degeneration. Klinische Monatsblatter fur Augenheilkunde, 2007, Volume: 224, Issue:4 Topics: Aged; Anti-Inflammatory Agents; Exudates and Transudates; Female; Humans; Injections; Macular Degeneration; Male; Retinal Detachment; Treatment Outcome; Triamcinolone Acetonide; Vision Disorders; Visual Acuity; Vitreous Body	2007
[Considerations about intravitreal triamcinolone use]. Archivos de la Sociedad Espanola de Oftalmologia, 2007, Volume: 82, Issue:6 Topics: Diabetic Retinopathy; Glucocorticoids; Humans; Injections; Macular Degeneration; Macular Edema; Triamcinolone Acetonide; Vitreous Body	2007
Combined photodynamic therapy and intravitreal triamcinolone for neovascular age-related macular degeneration: effect of initial visual acuity on treatment response. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2007, Volume: 245, Issue:11 Topics: Choroidal Neovascularization; Combined Modality Therapy; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Degeneration; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body	2007
The effect of intravitreal triamcinolone on foveal edema in exudative macular degeneration. American journal of ophthalmology, 2007, Volume: 144, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Female; Fovea Centralis; Glucocorticoids; Humans; Injections; Macular Degeneration; Macular Edema; Male; Middle Aged; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body	2007
[Position of the Retinological Society, the German Ophthalmological Society and the Professional Association of Ophthalmologists in Germany on the current therapeutic possibilities for neovascular age-related macular degeneration]. Klinische Monatsblatter fur Augenheilkunde, 2007, Volume: 224, Issue:7 Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Choroidal Neovascularization; Drug Therapy, Combination; Evidence-Based Medicine; Humans; Macular Degeneration; Ophthalmology; Photochemotherapy; Porphyrins; Pregnadienediols; Ranibizumab; Societies, Medical; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Verteporfin	2007
Retinal angiomatous proliferation: combined therapy of intravitreal triamcinolone acetonide and PDT versus PDT alone. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2008, Volume: 246, Issue:2 Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Injections; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Prospective Studies; Retinal Neovascularization; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body	2008
Evaluation of patient age as a risk factor for intraocular pressure elevation after intravitreal triamcinolone. American journal of ophthalmology, 2007, Volume: 144, Issue:3 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Macular Edema; Male; Middle Aged; Ocular Hypertension; Prospective Studies; Risk Factors; Triamcinolone Acetonide; Vitreous Body	2007
Effect of posterior juxtascleral triamcinolone acetonide on the efficacy and choriocapillaris hypoperfusion of photodynamic therapy. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2008, Volume: 246, Issue:3 Topics: Aged; Angiogenesis Inhibitors; Choroid; Choroidal Neovascularization; Coloring Agents; Female; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Injections; Macular Degeneration; Male; Photochemotherapy; Porphyrins; Retreatment; Tomography, Optical Coherence; Triamcinolone Acetonide; Verteporfin; Visual Acuity; Vitreous Body	2008
Viscocanalostomy for refractory glaucoma secondary to intravitreal triamcinolone acetonide injection. Archives of ophthalmology (Chicago, Ill. : 1960), 2007, Volume: 125, Issue:9 Topics: Aged; Female; Filtering Surgery; Glaucoma; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Macular Edema; Male; Middle Aged; Sclera; Surgical Flaps; Triamcinolone Acetonide	2007
[Subtenonial application of triamcinolone in neovascular form of senile macular degeneration]. Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti, 2007, Volume: 61, Issue:4 Topics: Aged; Aged, 80 and over; Female; Glucocorticoids; Humans; Injections; Macular Degeneration; Male; Middle Aged; Triamcinolone Acetonide	2007
Intravitreal bevacizumab and triamcinolone acetonide combination therapy for exudative neovascular age-related macular degeneration: short-term optical coherence tomography results. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2008, Volume: 24, Issue:1 Topics: Aging; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Drug Therapy, Combination; Humans; Intraocular Pressure; Macular Degeneration; Retina; Retrospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity	2008
Early effects of triamcinolone on vascular endothelial growth factor and endostatin in human choroidal neovascularization. Archives of ophthalmology (Chicago, Ill. : 1960), 2008, Volume: 126, Issue:2 Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antigens, CD34; Choroidal Neovascularization; Drug Therapy, Combination; Endostatins; Female; Humans; Immunoenzyme Techniques; Keratin-18; Macular Degeneration; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Porphyrins; Retrospective Studies; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Verteporfin	2008
A prospective study of early intraocular pressure changes after a single intravitreal triamcinolone injection. Journal of glaucoma, 2008, Volume: 17, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Choroidal Neovascularization; Female; Glucocorticoids; Gonioscopy; Humans; Injections; Intraocular Pressure; Macular Degeneration; Macular Edema; Male; Middle Aged; Prospective Studies; Retinal Vein Occlusion; Triamcinolone Acetonide; Vitreous Body	2008
Secondary ocular hypertension after intravitreal injection of 4 mg of triamcinolone acetonide: incidence and risk factors. Retina (Philadelphia, Pa.), 2008, Volume: 28, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Choroidal Neovascularization; Female; Glucocorticoids; Humans; Incidence; Injections; Intraocular Pressure; Macular Degeneration; Male; Middle Aged; Ocular Hypertension; Retrospective Studies; Risk Factors; Tonometry, Ocular; Triamcinolone Acetonide; Vitreous Body	2008
Intravitreal triamcinolone and elevated intraocular pressure. Australian and New Zealand journal of ophthalmology, 1999, Volume: 27, Issue:6 Topics: Fluorescein Angiography; Fundus Oculi; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Degeneration; Ocular Hypertension; Prospective Studies; Retinal Neovascularization; Risk Factors; Treatment Outcome; Triamcinolone Acetonide; Vitreous Body	1999
Triamcinolone acetonide modulates permeability and intercellular adhesion molecule-1 (ICAM-1) expression of the ECV304 cell line: implications for macular degeneration. Clinical and experimental immunology, 2000, Volume: 121, Issue:3 Topics: Animals; Anti-Inflammatory Agents; Blood-Retinal Barrier; Cell Line; Cell Membrane Permeability; Epithelial Cells; Histocompatibility Antigens Class I; Humans; Intercellular Adhesion Molecule-1; Macular Degeneration; Microscopy, Electron; Tetradecanoylphorbol Acetate; Triamcinolone Acetonide	2000
Effects of triamcinolone acetonide on microglial morphology and quantitative expression of MHC-II in exudative age-related macular degeneration. Clinical & experimental ophthalmology, 2001, Volume: 29, Issue:3 Topics: Aged; Aged, 80 and over; Choroidal Neovascularization; Down-Regulation; Female; Fluorescein Angiography; Fluorescent Antibody Technique, Indirect; Glucocorticoids; HLA-DR Antigens; Humans; Immunohistochemistry; Injections; Macular Degeneration; Microglia; Microscopy, Confocal; Triamcinolone Acetonide; Vitreous Body	2001